picstloup
27 Jul 2017
Very decent half year Profit up, revenue up, cash up, pipeline healthy; market cerainly likes it. Only thing stopping this from hitting £5 is the dragging on of the DoJ investigation, which they've made massive allowance for.
picstloup
07 Feb 2017
Takeover? The FT quotes: "If Indivior can navigate these legal risks while keeping market share steady, “it could become a target for a larger peer,” RBC said in a recent note. RBC named as potential bidders the privately owned Purdue Pharmaceuticals, along with listed peers Endo Pharmaceuticals, Allergan and Johnson & Johnson"
II Editor
20 Oct 2016
NEW ARTICLE: Don't write off reliable Reckitt Benckiser "With the fatal South Korean disinfectant scandal, tough Russian market and sluggish take-up of Scholl footwear products, LSE:RB.:Reckitt Benckiser missed City forecasts in the third quarter.It's proved a perfect excuse for shareholders to bank ..."[link]
picstloup
17 Aug 2016
Re: Time to bank profits? The Telegraph's Questor again showed his form in advising to sell these at £1.70 a couple of months ago, and now they are £3.42.The RB-6000 drug had good results in its phase 3 clinic trial, which apparently explains today's big rise.
picstloup
28 Jul 2016
Time to bank profits? Very nicely up on these (c90% on the initial RB stake, plus later top up), despite the occasionally bumpy ride. Had been thinking about taking some profits. But decided to wait to see what tomorrow's interims look like. Good that the $ exchange rate for the divi was decided when the £ had slumped down to $1.29.Couple of analysts have targets of £3.50 and £3.20, which would definitely be time to think about top slicing.
flexdream
03 Jun 2016
Re: What is up?! See the news thread. An Indivior patent has been upheld. Next week should be interesting.
flexdream
03 Jun 2016
Re: What is up?! lSee the news thread. An Indivior patent has been upheld. Next week should be interesting.
Merlindale
03 Jun 2016
What is up?! Lovely surprise today to see this up 34% - but why??
nk1999
20 Feb 2016
Telegraph- Questor "The Questor Column:Sell Indivior after a wild first year on the stock market: Indivior, the pharmaceutical company that was spun out of parent group Reckitt Benckiser at the end of 2014, has endured a wild first year to listed life and Questor still thinks the shares are looking risky. The company is based around the lucrative heroin addiction medication Suboxone, which has come under increasing pressure from cheap copycat versions as its patent protection ended. Sales were down 9% to $1 billion during the 12 months to the end of December, but that was only half the story. The company is having to slash prices to defend market share, so pretax profits halved to $285 million from $561 million a year earlier. The company expects profits to fall again in the year ahead, with net income targets of between $155 million and $180 million. But it could still get worse, as the company did not include the impact of competitors cutting prices further, or copying its film version of the drug (taking the Suboxone through an edible film) in those forecasts. A court ruling due within the next four months could clear the way for competitors to enter the film market. The shares may look incredibly cheap for a pharmaceutical company on just 10 times forecast earnings. But sales and profits are falling fast, and there is a very uncertain future for that major product, Suboxone. We remain negative. Sell. Indivior at 171p +23.3p. Questor says “Sell”.
flexdream
01 Dec 2015
Re: 2015 interim dividend of 3.2 US cent... I received mine on 23/10 into my ISA
Jidder W
26 Nov 2015
Re: 2015 interim dividend of 3.2 US cents I haven't received mine yet either. I have chased ii on 16th November and they have raised it with their "Dividends Team". I have to wait 10 working days for a reply...
Barcrog
25 Nov 2015
Re: 2015 interim dividend of 3.2 US cents I received mine on Oct 26 into my Barclays Stockbrokers account.
baylea
25 Nov 2015
2015 interim dividend of 3.2 US cents I haven't received this dividend from ii:The 2015 interim dividend of 3.2 US cents per ordinary share was declared by the board on July 28th, 2015. This dividend totalling $23m was paid on October 23rd to shareholders whose names appeared on the register of members at the close of business on September 18th, 2015. The sterling equivalent per ordinary share was set at 2.08 pence.Have other people received it?
aspace
16 Oct 2015
Re: OOPS! Well I certainly haven't recommended it. See my last post below where I argue that INDV's profits are illusory. I explained my reasoning backed up with references to the latest published annual report and sold out completely.
tradingup
08 Oct 2015
Re: OOPS! Flank - thank you for that helpful post. I noted after posting myself that all pharmas andhealth stocks were down yesterday. Indivior has been strongly recommended by variouspundits on iii - it does seem to be highly specialised and dependent for its growth on druggiesand winos.
